1/15
04:43 pm
ser
Serina Therapeutics receives NYSE notification [Seeking Alpha]
High
Report
Serina Therapeutics receives NYSE notification [Seeking Alpha]
1/15
04:30 pm
ser
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
High
Report
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
12/11
04:47 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry [Yahoo! Finance]
12/11
04:15 pm
ser
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Low
Report
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
12/10
04:30 pm
ser
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
Medium
Report
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
11/13
06:10 am
ser
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Low
Report
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
11/3
06:05 am
ser
Serina Therapeutics Provides Regulatory Update on SER-252 Program
Medium
Report
Serina Therapeutics Provides Regulatory Update on SER-252 Program